Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

Background: Statin medications reduce the risk of atherosclerotic cardiovascular disease (ASCVD). China’s new central government medicine procurement policy lowered statin prices by five-fold or more, which may impact the cost-effectiveness of statin therapy. Objective: To explore the impact of Chin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Miao Wang, Jing Liu, Brandon K. Bellows, Yue Qi, Jiayi Sun, Jun Liu, Andrew E. Moran, Dong Zhao
Formato: Artigo
Idioma:Inglês
Publicado em: Ubiquity Press 2020-06-01
Colecção:Global Heart
Assuntos:
cardiovascular disease
cost-effectiveness
low-density lipoprotein cholesterol
microsimulation
primary prevention
statins
Acesso em linha:https://globalheartjournal.com/articles/830
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados